More: Digestive Disease Week (DDW) 2008

DDW 2008: GERD/Acid-Related Disorders CME

May 17 - 22, 2008, San Diego, California

Author Information and Disclosures

This activity is not sanctioned by, nor a part of, Digestive Disease Week. Conference news does not receive grant support and is produced independently.

Release Date: June 30, 2008; Valid for credit through June 30, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of Digestive Disease Week. These materials and the related activity are not sanctioned by Digestive Disease Week or the commercial supporter of the conference and do not constitute an official part of that conference.

Copyright © 2008 Medscape.
Medscape
Learning Objectives
Upon completion of this activity, participants will be able to:
  1. Review and understand the evidence for the use of proton-pump inhibitors in the management of GERD and related conditions, including peptic ulcer disease
  2. Explore current and emerging therapeutic strategies in the setting of GERD/acid-related disorders
Authors and Disclosures

Brooks D. Cash, MD, FACP, FACG
Disclosure: Brooks D. Cash, MD, FACP, FACG, has disclosed that he has served as an advisor or consultant to Salix, Sucampo Pharmaceuticals, and Takeda.


Maria L. Gaiso, PhD
Disclosure: Maria L. Gaiso, PhD, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.